Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
about
The Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entryDevelopment and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR.Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.Chlamydia pneumoniae resists antibiotics in lymphocytes.Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strainsHuman blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae.Laboratory diagnosis of Chlamydia pneumoniae infections.The Type III Secretion System-Related CPn0809 from Chlamydia pneumoniaeDetection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection.Chlamydia pneumoniaeThe Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding.Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro.Improvement of growth of Chlamydia pneumoniae on HEp-2 cells by pretreatment with polyethylene glycol in combination with additional centrifugation and extension of culture time.Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patientsOptimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections.Novel Parachlamydia acanthamoebae quantification method based on coculture with amoebae.Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots.Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells.Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols.Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages.Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcriptsSurvival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activityUltrastructural study of Chlamydia pneumoniae in a continuous-infection model.cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection.Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection modelChlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s).Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay.
P2860
Q27334989-DB99003A-FD08-4A22-8A25-9F5053367C3AQ33885153-65FAD683-0998-4EA7-AA67-5E6641F156BFQ33965613-6FDBCAC6-2D6B-4AAD-B951-004EF48E9493Q33968165-C54B18A3-E097-421F-9D82-14F3D13F28C1Q33970414-144F119C-A8E0-4E77-AC76-B4375C973EB7Q33997961-A5EBCAC8-D304-41BC-B24E-F4A2DF83406FQ34752011-A7BF124B-9CAE-4E87-AD07-2AEFB92D6452Q34943465-074FA9A7-7221-4909-8FAD-051C820976A3Q35014062-B862E543-A7E9-48D6-85D3-2CF89CFEE522Q35188416-EA17FAB1-B7F7-47A3-9CBD-0AFB8EE9DB0DQ35502254-E974EF61-AD0B-4FE3-98F9-B2B6AA0D3402Q35892967-2BD1554D-31FF-450F-9A05-35B6D86C57AFQ35928664-D5CC9E22-1133-4698-B25D-52FC8B22C6C9Q36087554-3B94B6B4-D2C0-4878-A63F-E5289CA821FEQ36272565-84DD5DA6-834B-48E7-A792-BB69C999780AQ36437361-A45F2BD2-8E2E-433F-B42C-5D40FF04A293Q36539263-B35E4D68-1906-44D9-AEBE-F9ED10A682D5Q36545356-073E5604-16B4-4501-80DE-7C196AB6ED76Q36703071-20FA29D9-657D-4EE0-A1BA-726C89FD04B7Q37074513-3D6C81F1-47F2-4A2B-81E0-F7D2F40D5528Q37329763-5A6F4F0E-8242-4AD0-961F-27C129036BEBQ37843405-C3069EBC-C3FF-4E88-A27C-754E1E8BFE73Q37845251-01CD7FD1-AF1F-4E25-A18E-52BEA11962F9Q37852745-EF30DFF1-9DFF-4635-AAD1-36269BEF3D21Q37856695-D0BA5369-D1EE-4FB8-9F2D-E4AB091FB62DQ37860850-83F66F85-A909-48B5-BE25-51BDD99DBFC1Q37866228-343E2055-8098-4EA9-81FF-6E4E3C82196FQ37870755-2B74D620-5A99-4FD6-8FD6-BDB55E7EC1E0Q37871579-FED26CB6-34EB-4B5E-AF78-B5018660200FQ37872148-1168CDBD-DB78-428B-8A7A-C29D90B1FC67Q37872423-F366A122-3678-449A-B5CF-958A8A1AAF50Q37873270-2B33921F-5B71-41DF-B4BB-21CCD47EB11FQ37873353-7EEC7E75-9D40-4B31-BAE8-34FE03B0E9CCQ37874954-6CE10D28-1A79-4A7D-9CF9-93F25892AB4DQ37877470-82A19395-830B-419F-96B9-1DEBC161993DQ37877492-EFBBDB4D-AEE9-4E5C-BD3A-12370BAECA55Q37877605-7E2351CD-1355-4FF8-B79F-67A460E3228AQ37877849-C6036247-BB74-4F8C-A078-D680E97F3D4EQ37878378-9D627AB0-3343-4893-AFFA-AA894BDC0A94Q37880695-D575B226-EE1C-4ED8-AB0C-82BF5BDDC270
P2860
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@en
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@nl
type
label
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@en
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@nl
prefLabel
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@en
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@nl
P2093
P2860
P1476
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.
@en
P2093
Dumornay W
Hammerschlag MR
P2860
P304
P407
P577
1992-08-01T00:00:00Z